Stoke Therapeutics (STOK) EBT Margin Growth (1y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -2,817.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,558.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -683.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,688.00
10 Stoke Therapeutics 1.92 Bn 1.92 Bn - -87,474.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -87,474.00
Dec 31, 2025 -407,715.00
Sep 30, 2025 16,735.00
Jun 30, 2025 36,192.00
Mar 31, 2025 69,756.00
Dec 31, 2024 91,632.00
Sep 30, 2024 20,309.00
Jun 30, 2024 70,533.00
Mar 31, 2024 -18,716.00
Dec 31, 2023 -17,724.00
Sep 30, 2023 15,714.00
Jun 30, 2023 -47,292.00
Mar 31, 2023 38,462.00